Skip to content

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

An Analysis Into the Cause and Preventional Method of Thromboembolic Disease in Gynecological Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03644992
Enrollment
54
Registered
2018-08-24
Start date
2022-09-01
Completion date
2022-10-01
Last updated
2020-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological Surgery, Thromboembolic Disease

Brief summary

The aim of this cross-sectional study is to describe the specific situations of thromboembolic disease in gynecological surgery and identify the risk factors of it.

Detailed description

The electronic medical data of 54 patients who undergo operations to treat gynecological diseases but develop thromboembolic disease will be analyzed retrospectively in this study. The location, symptom and other situations of embolism will be described and multiple linear analyse will be employed to identify the risk factors of it.

Interventions

None listed

Sponsors

Second Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Volunteer to participate in the study with informed consent; 2. Females aged 20-80 who are confirmed with some gynecological diseases and are treated with surgery but embolism happens unfortunately.

Exclusion criteria

1. Pregnancy, lactation, postmenopause, or planned pregnancy within two years; 2. Patients with blood diseases prone to thrombosis and those with a history of thrombus were excluded; 3. History of hyperparathyroidism, infectious diseases (tuberculosis, AIDS), autoimmune diseases, or digestive system diseases (malabsorption, crohn disease and dysentery); 4. Other diseases or heavy injuries that will interfere with the results; 5. Simultaneous participation in another clinical study with investigational medicinal product(s) or researcher thinks the subjects are not suitable for this trial.

Design outcomes

Primary

MeasureTime frameDescription
the percentage of different symptoms of thromboembolic disease(%)10 months after the operationdifferent patients will have various symptoms of embolism like dyspnea, chest pain, hemoptysis and syncope. And we plan to describe the distribution of it.

Secondary

MeasureTime frameDescription
the location of embolism10 months after the operationembolism can occur in different parts like the brain, limb, pulmonary and coronary systems. We plan to summarize the location of embolism.
the risk factors of thromboembolic disease10 months after the operationPerforming multiple linear regression analysis with statistical product and service solutions(SPSS) 17.0, we plan to identify the risk factors which can increase the possibility of thromboembolic disease from possible factors like hypertension, diabetes, etc.

Countries

China

Contacts

Primary ContactQiong ZHANG, Ph.D.
joan_zhang2002@sina.com13587605820

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026